tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SVRA Stock Latest News

Savara downgraded to In Line from Outperform at Evercore ISI
The FlySavara downgraded to In Line from Outperform at Evercore ISI
13d ago
SVRA
Savara price target lowered to $6 from $10 at H.C. Wainwright
PremiumThe Fly
Savara price target lowered to $6 from $10 at H.C. Wainwright
13d ago
SVRA
Savara management to meet virtually with Piper Sandler
PremiumThe Fly
Savara management to meet virtually with Piper Sandler
2M ago
SVRA
3 Best Stocks to Buy Now, 10/1/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 10/1/2024, According to Top Analysts 
2M ago
CCL
SVRA
Savara announces EAP for molgramostim for patients with aPAP
PremiumThe Fly
Savara announces EAP for molgramostim for patients with aPAP
2M ago
SVRA
Savara appoints Braden Parker as chief commercial officer
PremiumThe FlySavara appoints Braden Parker as chief commercial officer
2M ago
SVRA
Savara announces new data from Pivotal Phase 3 IMPALA-2 trial
Premium
The Fly
Savara announces new data from Pivotal Phase 3 IMPALA-2 trial
3M ago
SVRA
Savara price target lowered to $9 from $10 at JMP Securities
Premium
The Fly
Savara price target lowered to $9 from $10 at JMP Securities
4M ago
SVRA
Savara reports Q2 EPS (12c), consensus (11c)
PremiumThe Fly
Savara reports Q2 EPS (12c), consensus (11c)
4M ago
SVRA
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
5M ago
DJT
AISP
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
WVE
CASI
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
5M ago
ACB
TBT
Savara price target raised to $10 from $8 at Guggenheim
PremiumThe FlySavara price target raised to $10 from $8 at Guggenheim
5M ago
SVRA
Savara price target raised to $10 from $6 at H.C. Wainwright
Premium
The Fly
Savara price target raised to $10 from $6 at H.C. Wainwright
5M ago
SVRA
Savara price target raised to $15 from $11 at Oppenheimer
Premium
The Fly
Savara price target raised to $15 from $11 at Oppenheimer
5M ago
SVRA
Jefferies sees 50%-100% stock move possible after Savara Phase 3 success
PremiumThe Fly
Jefferies sees 50%-100% stock move possible after Savara Phase 3 success
5M ago
SVRA
Savara’s IMPALA-2 Trial Success and FDA Submission Plan
PremiumCompany Announcements
Savara’s IMPALA-2 Trial Success and FDA Submission Plan
5M ago
8K
SVRA
Savara reports results from pivotal Phase 3 IMPALA-2 clinical trial.
PremiumThe Fly
Savara reports results from pivotal Phase 3 IMPALA-2 clinical trial.
5M ago
SVRA
Savara price target raised to $11 from $9.50 at Oppenheimer
PremiumThe Fly
Savara price target raised to $11 from $9.50 at Oppenheimer
6M ago
SVRA
Savara price target lowered to $7 from $10 at Evercore ISI
PremiumThe FlySavara price target lowered to $7 from $10 at Evercore ISI
6M ago
SVRA
Savara files $400M mixed securities shelf
Premium
The Fly
Savara files $400M mixed securities shelf
7M ago
SVRA
Savara reports Q1 EPS (11c), consensus (10c)
Premium
The Fly
Savara reports Q1 EPS (11c), consensus (10c)
7M ago
SVRA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >